P035 SLC26A9 promotes the development and stemness of triple-negative breast cancer via activating EGFR/PI3 K/AKT signaling pathway. (April 2023) - Zhou, Z.; Ma, Z.; Lu, C.; Liu, X.; Lv, J.; Zhang, C.; Wang, H.; Mu, R.; Cheng, X.; Tuo, B.; Li, T.